August 5, 2025 Sophia Vida
Breaking News

Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts

Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume growth for the first time and expects continued QOQ growth for the remainder of the year Cost-effectiveness analysis demonstrating Nociscan is more … Continue reading “Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts”